Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Cambridge based CTO’ operating in the Biotechnology space. If you think a CTO’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Aditya Khosla
Co-founder & CTO of PathAI
Aditya recently completed his PhD in machine learning and computer vision at MIT. He completed his MS at Stanford in 2011 and BS at Caltech in 2009. In his research he developed new methods for an array of applications in computer vision, including eye-tracking, prediction of image memorability, and visualization of deep networks. He is the recipient of a Facebook Fellowship and his work has been widely covered by various media outlets including BBC, The New York Times and The Washington Post. He has published over 30 papers in the fields of deep learning, computer vision and neuroscience.
Follow Aditya Khosla:
About PathAI: PathAI is developing technology that assists pathologists in making rapid and accurate diagnoses for every patient, every time.
Matthew Hayes
CTO of evonetix
Matthew Hayes is the Interim CEO and CTO at Evonetix.
Follow Matthew Hayes:
About evonetix: Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.
Giulio Ruffini
President, CTO, Co-Founder of Neuroelectrics
Follow Giulio Ruffini:
About Neuroelectrics: Neuroelectrics is a digital brain health company that diagnoses and treats brain disorders, and improves overall brain health.
Irene Bosch
Co-founder & CTO of E25Bio
Irene Bosch serves as the CEO and founder of E25Bio.
Follow Irene Bosch:
About E25Bio: E25Bio specializes in the development of rapid diagnostic tests for epidemic fever viruses.
Tom Lowery
Chief Technology Officer of Satellite Bio
Tom Lowery is the Chief Technology Officer at Satellite Bio.
Follow Tom Lowery:
About Satellite Bio: Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.
Paul Herzich
Chief Technology Officer of AavantiBio
Paul Herzich is the Chief Technology Officer at AavantiBio.
Follow Paul Herzich:
About AavantiBio: AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.
Chad Nusbaum
Chief Technology Officer of Cellarity
Chad Nusbaum is the Chief Technology Officer at Cellarity.
Follow Chad Nusbaum:
About Cellarity: Cellarity’s platform digitizes the molecular information in cells to elucidate how they behave in health and disease.
Mason Edwards
Founder & CTO of Synbiota
Mason Edwards is Founder & CTO at Synbiota.
Follow Mason Edwards:
About Synbiota, Tezos Foundation: Helping scientists make big discoveries faster, cheaper, and global.
Derek Stemple
CTO and Co-Founder of Camena Bioscience
Derek Stemple is the CTO and co-founder of Camena Bioscience. He previously held senior positions at the Wellcome Trust Sanger Institute and was a lab head at the National Institute for Medical Research. Derek holds a Ph.D. from the California Institute of Technology.
Follow Derek Stemple:
About Camena Bioscience: Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications.
Jane Osbourn
Co-Founder, Chief Scientific Officer & Chief Technology Officer of Alchemab Therapeutics
Jane Osbourn is the chairman at Mogrify.
Follow Jane Osbourn:
About Alchemab Therapeutics: Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases.
William Jones
CTO & Co-Founder of Sano Genetics
Follow William Jones:
About Sano Genetics: Sano Genetics is a personalised medicine research platform with data privacy and transparency at its core.
Kevin Lee
CTO and Co-Founder of Erbi Biosystems
Kevin Lee is the Chief Technology Officer and Co-founder of Erbi Biosystems.
Follow Kevin Lee:
About Erbi Biosystems: Erbi Biosystems is a transformative microfluidic bioprocess instrumentation company.
Gordon McInroy
Founder and CTO of Nuclera
Follow Gordon McInroy:
About Nuclera: Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.
Miriam Huntley
CTO & Co-founder of Day Zero Diagnostics
Miriam Huntley is CTO and Co-founder at Day Zero Diagnostics.
Follow Miriam Huntley:
About Day Zero Diagnostics: The future of infectious disease diagnostics starts at Day Zero.
Gustavo Cerda
CTO of Swift Molecular Diagnostics
Gustavo completed his PhD at the University of Cambridge in the field of molecular biology. He then went on to do a successful Post-doc also at the University of Cambridge. Using his knowledge of molecular biology, he discovered a revolutionary method of detecting DNA. He now works full time for Swift Molecular Diagnostics.
Follow Gustavo Cerda:
About Swift Molecular Diagnostics: Swift Molecular Diagnostics is developing a rapid, easy-to-use, cost effective genetic “yes or no” test.
Christopher Loose
Co-Founder and Chief Technology Officer of Semprus BioSciences
Follow Christopher Loose:
About Semprus BioSciences: Semprus BioSciences is a venture-backed biomedical company developing medical devices implementing the Semprus technology.
Steven Moss
Chief Technology Officer of Isomerase Therapeutics
Steven is highly practiced at applying the chemical biology of microbial natural products to drug discovery. In particular, Steven is experienced in applying Isomerase’s bioengineering platform and semi-synthesis to generate microbial natural products with characteristics more suited to use as pharmaceuticals than the parent. From 2009 until 2013, Steven was the Director of Natural Products Chemistry at Biotica Technology Ltd., where he was responsible for all internal fermentation and chemistry as well as the management and technology transfer associated with outsourced manufacture and chemistry. Steven joined Biotica in 2002 as a Research Scientist and worked on a number of different microbial natural product based programmes across multiple therapeutic areas. Prior to that, he spent two years as a Post-Doctoral Research Associate with Professor Heinz G. Floss (University of Washington, Seattle) studying the biosynthesis of ansamitocin. Steven holds a BSc and PhD in Chemistry from the University of Durham, where he studied under Professor David O’Hagan. He is an author or inventor on over 40 scientific papers and US/EU patents.
Follow Steven Moss:
About Isomerase Therapeutics: Isomerase Therapeutics is an agile drug discovery and development company.
Justin Buckland
CTO of LEX Diagnostics
Justin Buckland is the Chief Technology Officer of LEX Diagnostics.
Follow Justin Buckland:
About LEX Diagnostics: LEX Diagnostics is a medical device company that specializes in molecular diagnostics for primary care.
David Mosedale
CTO of Methuselah Health
David Mosedale is the CTO at Methuselah Health.
Follow David Mosedale:
About Methuselah Health: Methuselah Health identifies novel targets for treatment of ageing-related diseases.
